Patents Represented by Attorney, Agent or Law Firm Steve T. Zelson, Esq.
  • Patent number: 6136571
    Abstract: The present invention relates to a method for the production of saccharide preparations, i.e., syrups, by saccharifying a liquefied starch solution, which method comprises a saccharification step during which step one or more enzymatic saccharification stages takes place, and the subsequent steps of one or more high temperature membrane separation steps, and re-circulation of the saccharification enzyme, in which method the membrane separation steps are carried out as an integral part of the saccharification step. In another specific aspect, the invention provides a method of producing a saccharide preparation, which method comprises an enzymatic saccharification step, and the subsequent steps of one or more high temperature membrane separation steps and re-circulation of the saccharification enzyme.
    Type: Grant
    Filed: February 10, 2000
    Date of Patent: October 24, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Gin C. Liaw, Sven Pedersen, Hanne Vang Hendriksen, Allan Svendsen, Bjarne R.o slashed.nfeldt Nielsen, Ruby Illum Nielsen
  • Patent number: 6127343
    Abstract: The present invention relates to compounds, compositions containing them, and their use for treating medical disorders related to binding to human somatostatin receptor subtypes.
    Type: Grant
    Filed: May 12, 1997
    Date of Patent: October 3, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Michael Ankersen, Carsten Enggaard Sitdsen, Henrik Sune Andersen
  • Patent number: 6127334
    Abstract: Insulin preparations of superior physical stability, comprising dissolved and/or precipitated human insulin or an analogue or derivative thereof, and a water-soluble reduced or non-reducing carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or a water-soluble non-reducing ester and/or ether derivative of a carbohydrate or reduced carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or mixtures thereof are disclosed.
    Type: Grant
    Filed: November 24, 1998
    Date of Patent: October 3, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Lone L.o slashed.gstrup Kimer, Per Balschmidt, Steen Jensen
  • Patent number: 6126646
    Abstract: A plastic adaptor top for adapting to a chosen syringe a standard cartridge of the kind having a neck with a flange and being closed by a rubber membrane sealingly secured against the flange by a metal cover having its edge beaded behind the flange. This plastic top has a bore for receiving the neck part of the cartridge, which bore has a diameter making it fit over the metal cover and is provided with protrusions gripping behind the edge of the metal cover when the neck part is inserted in the bore. The outer contour of the adaptor top is provided with threads coaxial with the bore to receive a needle hub in a way causing the needle to penetrate the membrane of the cartridge when the hub is mounted on the thread of the plastic top.
    Type: Grant
    Filed: July 29, 1997
    Date of Patent: October 3, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Ib Hansen, S.o slashed.ren Mikkelsen, Frits Frydendal Bonnichsen
  • Patent number: 6124127
    Abstract: The present invention relates to microbial pectate lyases, more specifically to microbial enzymes exhibiting pectate lyase activity as their major enzymatic activity in the neutral and alkaline pH ranges, to a method of producing such enzymes, and to methods for using such enzymes in the textile, detergent and cellulose fiber processing industries.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: September 26, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Lene Nonboe Andersen, Martin Schulein, Niels Erik Krebs Lange
  • Patent number: 6114509
    Abstract: The invention relates to modified polypeptides with reduced allergenicity comprising a parent polypeptide with a molecular weight from between 10 kDa and 100 kDa conjugated to a polymer with a molecular weight (M.sub.r) in the range of 1 kDa and 60 kDa. The modified polypeptide are produced using a process including the step of conjugating from 1 to 30 polymer molecules with the parent polypeptide. Further the invention relates to compositions comprising said polypeptides and further ingredients normally used in e.g. detergents, including dishwashing detergents and soap bars, household article, agrochemicals, personal care products, cosmetics, toiletries, oral and dermal pharmaceuticals, composition for treating textiles, and compositions used for manufacturing food and feed. Finally the invention is directed to uses of polypeptides with reduced allergenicity or compositions thereof for reducing the allergenicity of products for a vast number of industrial applications.
    Type: Grant
    Filed: September 20, 1999
    Date of Patent: September 5, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Arne Agerlin Olsen, Lars Bo Hansen, Thomas Christian Beck
  • Patent number: 6114296
    Abstract: The present invention provides variants of a parent cellulase, such as, e.g., a cellulase classified in family 45 such as a Humicola insolens 43 kD endoglucanase, comprising a cellulose binding domain (CBD), a catalytically active domain (CAD), and a region linking the CBD and CAD (the linking region), wherein one or more amino acid residues of the CBD, CAD, or linking region is deleted or substituted by one or more amino acid residues and/or one or more amino acids are added to the linking region and/or another CBD is added at the opposite end of the CAD. Such variants have improved properties as regards, e.g., alkaline activity, compatibility with detergent composition ingredients, particular soil removal, color clarification, defuzzing, depilling, harshness reduction, and sensitivity to anionic surfactants. Such variants are useful, e.g., in detergent compositions, for textile treatment, in paper pulp processing, for animal feed, and for stone-washing of jeans.
    Type: Grant
    Filed: April 8, 1998
    Date of Patent: September 5, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Martin Schulein, Henrik Fredholm, Carsten Mailand Hjorth, Grethe Rasmussen, Egon Nielsen, Peter Rosholm
  • Patent number: 6110149
    Abstract: The present invention relates to syringes for apportioning set doses from an ampoule has a dose setting and injection mechanism comprising a dose setting member which may be moved in one direction to set a dose and in the opposite direction to inject the set dose. A piston advancing mechanism comprises a piston rod and a piston rod drive, and the dose setting and injection mechanism is coupled to the piston advancing mechanism through a unidirectional coupling transmitting only movement of the dose setting member in the dose injecting direction to the piston rod drive. Operation of an air shot button enables influence on the piston advancing mechanism to advance the piston to expel an adjustable fixed volume. The air shot button is either coupled to the piston rod drive through a unidirectional coupling through which the piston rod is advanced when the air shot button is pressed, or it moves the end stop for an injection button so that this button may be pressed beyond its normal depressed end position.
    Type: Grant
    Filed: September 9, 1997
    Date of Patent: August 29, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Christian Peter Klitgaard, Steffen Hansen, Gabriel J.o slashed.rgensen
  • Patent number: 6110703
    Abstract: The present invention relates to a novel method for the production of short chain polypeptides, including polypeptides having up to 3 disulfide bonds and/or structures rich in basic amino acid residues, and open structured short chain polypeptides, e.g. glucagon, glucagon like peptides and their functional analogues, in genetically modified yeast cells, said genetically modified yeast cells, and a method for the preparation of said yeast cells.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: August 29, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Michi Egel-Mitani, Jakob Brandt, Knud Vad
  • Patent number: 6106828
    Abstract: The present invention provides polypeptide conjugates with reduced allergenicity comprising a polymeric carrier molecule having two or more polypeptide molecules coupled thereto. The invention also provides methods for producing the conjugates, compositions comprising the conjugates, and the use of the conjugates in industrial applications, including personal care products and detergent compositions.
    Type: Grant
    Filed: July 28, 1998
    Date of Patent: August 22, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bisgard-Frantzen, Arne Agerlin Olsen, Annette Prento
  • Patent number: 6107455
    Abstract: A method for lowering the extractable protein content in a natural rubber latex to below 30 parts per million (ppm) comprises the steps of treating by washing a rubber article, such as a rubber glove, with an aqueous solution containing a soluble silicate and, optionally, a protease. The methods claimed effectively reduce the allergenicity of the articles so treated.
    Type: Grant
    Filed: December 8, 1997
    Date of Patent: August 22, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Peter Rosholm, Kai Chuang Heng, S.o slashed.ren H.o slashed.jfeldt Lund
  • Patent number: 6103505
    Abstract: The present invention relates to a method for reducing the content of phosphorous containing components in an edible oil comprising a high amount of non-hydratable phosphorous content, wherein the method comprises use of a phospholipase. Further the present invention relates to an enzyme with phospholipase activity, a cloned DNA sequence encoding the enzyme with phospholipase activity, a method of producing the enzyme, and the use of enzyme for a number of industrial applications.
    Type: Grant
    Filed: December 9, 1997
    Date of Patent: August 15, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Ib Groth Clausen, Shamkant Anant Patkar, Kim Borch, Martin Barfoed, Kim Clausen, Claus Crone Fuglsang, Lone Dybdal, Torben Halkier
  • Patent number: 6100063
    Abstract: A prokaryotic cell expressing a gene of interest and comprising at least two copies of said gene on the chromosome.
    Type: Grant
    Filed: February 11, 1999
    Date of Patent: August 8, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Steen Troels J.o slashed.rgensen
  • Patent number: 6099588
    Abstract: The present invention provides a method of treating wool, wool fibers or animal hair an alkali-containing alcohol solution, followed by a proteolytic enzyme in aqueous solution. The described method results in improved shrink-resistance, and may result in improvements in handle, appearance, wettability, reduction of felting tendency, increased whiteness, reduction of pilling, improved softness, improved tensile strength, and improved dyeing characteristics such as dye uptake and dye washfastness.
    Type: Grant
    Filed: February 23, 1999
    Date of Patent: August 8, 2000
    Assignee: Novo Nordisk Biochem North America, Inc.
    Inventors: Jason Patrick McDevitt, Xianghong Caroline Shi
  • Patent number: 6100080
    Abstract: A method for cleaning and disinfecting a surface at least partly covered by a biofilm layer comprising the steps of contacting the biofilm with a cleaning composition comprising one or more hydrolases, e.g. a hydrolytic enzyme produced by a strain of the fungus Aspergillus aculeatus, in an amount effective for either fully or partly removing or releasing the biofilm layer from the surface; and contacting the biofilm with a bactericidal disinfecting composition comprising an oxidoreductase such as an oxidase, a peroxidase or a laccase, in an amount effective for killing the living bacterial cells present in the biofilm. In particular, a disinfecting composition comprising laccase at concentration between about 0.01 to about 1000 mg protein/ml composition and an oxidation enhancer such as methyl syringate.
    Type: Grant
    Filed: December 15, 1997
    Date of Patent: August 8, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Charlotte Johansen
  • Patent number: 6100053
    Abstract: Transglutaminase preparations are producible by a wide range of fungi, especially ascomycotina, basidiomycotina and zygomycota, and gram-negative and gram-positive bacteria, especially Streptomyces lydicus, NRRL B-3446. A DNA construct encoding a novel transglutaminase and comprising the DNA sequence obtainable from the plasmid in E. coli, DSM 10175, is also described together with a method of producing the transglutaminases, a composition comprising the transglutaminase and a method for producing a gel or protein gelation composition.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: August 8, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Lisbeth Bech, Iben Angelica N.o slashed.rrevang, Torben Halkier, Grethe Rasmussen, Thomas Schafer, Jens T.o slashed.nne Andersen
  • Patent number: 6093562
    Abstract: The present invention relates to variants of a parent .alpha.-amylase, which parent .alpha.-amylase (i) has an amino acid sequence selected from the amino acid sequences shown in SEQ ID No. 1, SEQ ID No. 2, SEQ ID No. 3, and SEQ ID No. 7, respectively; or (ii) displays at least 80% homology with one or more of these amino acid sequences; and/or displays immunological cross-reactivity with an antibody raised against an .alpha.-amylase having one of these amino acid sequences; and/or is encoded by a DNA sequence which hybridizes with the same probe as a DNA sequence encoding an .alpha.-amylase having one of these amino acid sequences; in which variant:(a) at least one amino acid residue of the parent .alpha.-amylase has been deleted; and/or(b) at least one amino acid residue of the parent .alpha.-amylase has been replaced by a different amino acid residue; and/or(c) at least one amino acid residue has been inserted relative to the parent .alpha.-amylase; the variant having .alpha.
    Type: Grant
    Filed: February 13, 1996
    Date of Patent: July 25, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Henrik Bisg.ang.rd-Frantzen, Allan Svendsen, Torben Vedel Borchert
  • Patent number: 6087135
    Abstract: The present invention deals with a process for oxidation of a hydroxy group of C.sub.1 and/or C.sub.2 and/or C.sub.3 and/or C.sub.4 and/or C.sub.5 and/or C.sub.6 of a sugar monomer of an oligo- or a polysaccharide comprising contacting, in an aqueous medium, the oligo- or the polysaccharide with a phenol oxidizing enzyme and an enhancing agent, whereby an oligo- or a polysaccharide with altered characteristics compared to the native oligo- or polysaccharide is created.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: July 11, 2000
    Assignee: Novo Nordisk A/S
    Inventor: Jesper Vallentin Kierulff
  • Patent number: 6087315
    Abstract: The present invention relates to protease variants, stabilized towards the inactivation caused by peroxidase systems, in which protease variants a naturally occurring tyrosine residue has been deleted or substituted with a different amino acid residue at one or more positions. The invention also relates to a method of stabilizing a protease towards the inactivation caused by peroxidase systems, and detergent compositions comprising a protease variant of the invention.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: July 11, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Grethe Rasmussen, Egon Nielsen, Torben Halkier
  • Patent number: 6087149
    Abstract: The present invention relates to a starch conversion process of the type which includes a debranching step wherein an isoamylase being active at the process conditions prevailing is used for debranching the starch and to the use of thermostable isoamylases for starch conversion. The invention further relates to an isolated isoamylase obtained from a strain of the genus Rhodothermus and to cloned DNA sequences encoding isoamylases derived from a strain of Rhodothermus or Sulfolobus, to expression vectors comprising said DNA sequence, host cells comprising such expression vectors, and finally to methods for producing said isoamylases.
    Type: Grant
    Filed: August 4, 1998
    Date of Patent: July 11, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Noriko Tsutsumi, Henrik Bisg.ang.rd-Frantzen, Allan Svendsen